Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, represents a major cause of morbidity and mortality in patients with cancer. Low molecular weight heparins are the preferred option for anticoagulation in cancer patients according to current clinical practice gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Outes, Antonio, Suárez-Gea, M Luisa, Lecumberri, Ramón, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio, Rocha, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652561/
https://www.ncbi.nlm.nih.gov/pubmed/23674896
http://dx.doi.org/10.2147/VHRM.S35843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652561/
https://www.ncbi.nlm.nih.gov/pubmed/23674896
http://dx.doi.org/10.2147/VHRM.S35843

Ejemplares similares